ArticleBrain sciences2022

Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Olfactory Neuroblastoma.

Yu-Ju Tseng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.